LCM
STIM icon

Legato Capital Management’s Neuronetics STIM Stock Holding History

Legato Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24,540
Closed -$44.2K – 622
2024
Q2 		$44.2K Buy
+24,540
New +$70.8K 0.01% 547

Other funds holding STIM

KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legato Capital Management's STIM Position: Q3 2024 in Review

Legato Capital Management sold out of Neuronetics (STIM) in Q3 2024, closing a stake of 24,540 shares — an estimated $44.2K sold.

Legato Capital Management first reported a position in STIM in Q2 2024 and held it in 1 quarter. The position peaked at $44.2K in Q2 2024. 48 funds tracked by Wall St. Rank hold STIM as of Q3 2024.

  • Legato Capital Management reported no remaining Neuronetics position as of Q3 2024 after selling out during the quarter.
  • Legato Capital Management sold 24,540 Neuronetics shares in Q3 2024, an estimated $44.2K.
  • Legato Capital Management first reported a position in Neuronetics in Q2 2024 and held it in 1 quarter.
  • Legato Capital Management's Neuronetics position peaked at $44.2K in Q2 2024.
  • 48 funds tracked by Wall St. Rank held Neuronetics as of Q3 2024.

Based on Legato Capital Management's 13F filing for Q3 2024, filed 7 Nov 2024.